Anti‐S100A4 monoclonal antibody treatment ameliorates experimental skin fibrosis and SSc‐specific transcriptional signatures in human skin: Comment on the targeting S100A4 is helpful in SSc treatment by Trinh‐Minh et al

Disclosure form Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.